Systemic sclerosis

1. High-Yield Summary

Systemic sclerosis (SSc, scleroderma) is a multisystem autoimmune connective tissue disease defined by a triad of obliterative microvascular vasculopathy, profound immune dysregulation with specific autoantibody production, and progressive cutaneous and visceral fibrosis:

• Dichotomous Clinical Subtypes: Patients present primarily as either limited cutaneous systemic sclerosis (lcSSc / CREST syndrome: calcinosis, Raynaud’s, esophageal dysmotility, sclerodactyly, telangiectasia; anti-centromere antibody positive; skin thickening distal to elbows and knees) or diffuse cutaneous systemic sclerosis (dcSSc: anti-Scl-70 or anti-RNA polymerase III positive; rapid proximal skin induration, tendon friction rubs, and early life-threatening interstitial lung disease and scleroderma renal crisis).
• Pathognomonic Musculoskeletal Manifestations: Musculoskeletal pathology predominantly involves the hand and wrist, presenting with severe Raynaud’s phenomenon, painful ischemic digital ulcers, acro-osteolysis of distal phalanges, dystrophic calcinosis cutis, and progressive flexion contractures of the proximal interphalangeal (PIP) joints paired with thumb adduction contractures.
• Validated Diagnostic Threshold: The 2013 ACR/EULAR Classification Criteria require a score of 9 points or greater for definitive diagnosis; bilateral finger skin thickening extending proximal to the metacarpophalangeal (MCP) joints is sufficient as a standalone criterion (9 points).
• Vascular and Revascularization Hierarchy: Nonoperative medical optimization is mandatory prior to surgery, employing dihydropyridine calcium channel blockers, phosphodiesterase-5 (PDE-5) inhibitors, endothelin receptor antagonists, and prostacyclin analogues. Refractory ischemic digital ulcers warrant interventional salvage via targeted botulinum toxin A (chemical sympathectomy) or open adventitial periarterial digital sympathectomy, achieving 80% to 92% ulcer healing.
• Surgical Principle & Arthroplasty Prohibition: Revascularization must strictly precede deformity correction. PIP joint arthroplasty is absolutely contraindicated due to severe periarticular capsulofibrosis, compromised soft-tissue envelope, and excessive implant extrusion rates; PIP and DIP joint arthrodesis in functional positions represents the definitive operative standard.

2. Anatomy

Microvascular Hand Architecture & Obliterative Vasculopathy

The vascular supply of the hand relies on the confluence of the radial and ulnar arteries forming the superficial and deep palmar arches. The superficial palmar arch, derived predominantly from the ulnar artery, gives rise to three common digital arteries that travel in the intermetacarpal spaces deep to the palmar aponeurosis. At the level of the web spaces, each common digital artery receives a palmar metacarpal artery from the deep palmar arch before bifurcating into proper digital arteries that course along the ventrolateral aspect of the digits, dorsal to the proper digital nerves.

In systemic sclerosis, microvascular obliterative vasculopathy preferentially targets the proper digital arteries and the ulnar artery. Up to 50% of patients develop complete segmental ulnar artery occlusion within or proximal to Guyon’s canal. The proper digital arteries exhibit progressive concentric intimal hyperplasia, smooth muscle hypertrophy, and perivascular fibrosis, leading to severe luminal stenosis and terminal microthrombosis. The digital collateral pathways (transverse communicating branches and dorsal digital branches) are simultaneously attenuated, depriving the distal digital pulp and nail bed of capillary inflow.

Neurovascular Danger Zones

Surgical intervention in the scleroderma hand involves critical neurovascular danger zones heightened by severe soft-tissue atrophy and cutaneous tethering:

• Volar Digital Neurovascular Bundles: Proper digital arteries and nerves travel immediately adjacent to Grayson’s ligament (volar to the bundle) and Cleland’s ligament (dorsal to the bundle). Progressive dermal sclerosis obliterates normal subcutaneous adipose tissue planes, causing the neurovascular bundle to become tightly bound to the overlying dermis and flexor tendon sheath. During calcinosis excision or contracture release, these bundles are vulnerable to inadvertent transection or thermal injury from electrocautery.
• Bifurcation of Common Digital Arteries: Situated approximately 5 mm proximal to the web space margin. Distal dissection or aggressive release of the natatory ligaments during web space contracture release directly endangers this bifurcation.
• Ulnar Nerve & Artery in Guyon’s Canal: Bounded by the pisiform medially, the hook of the hamate laterally, and the volar carpal ligament anteriorly. Fibrotic thickening of the volar carpal ligament can cause secondary ulnar nerve entrapment while exacerbating concomitant ulnar artery compression.

Internervous Planes & Surgical Exposure Intervals

Standard surgical intervals must be modified to account for poor tissue compliance and compromised cutaneous vascularity:

• Palmar Digital Sympathectomy Interval: Accessed through longitudinal or transverse palmar incisions placed along the distal palmar flexion crease, avoiding longitudinal crossing of flexion creases. The plane of dissection stays strictly superficial to the flexor tendons and deep to the palmar fascia, isolating the common digital arteries proximal to their bifurcation.
• Midlateral Digital Approach: Placed along the neutral line connecting the apices of the flexion creases, strictly dorsal to the digital neurovascular bundle and volar to the extensor apparatus. This interval provides safe access to the PIP joint capsule, collateral ligaments, and retrovascular calcinosis deposits while minimizing tension on the volar skin during postoperative extension.
• First Web Space Z-Plasty Interval: Utilizes the internervous border between the median-innervated thenar musculature (abductor pollicis brevis, opponens pollicis) and the ulnar-innervated adductor pollicis and first dorsal interosseous muscles. The radial digital artery of the index finger and the princeps pollicis artery must be visualized and protected when releasing the deep fascia of the adductor pollicis.

Critical Musculoskeletal & Bony Landmarks

Key bony and soft-tissue landmarks dictating reconstructive interventions include:

• Distal Phalangeal Tuft: The primary site of acro-osteolysis. Lysis of the ungual tuberosity causes shortening of the distal phalanx, retraction of the nail bed, and dorsal soft-tissue puckering (“beak-like” claw nail deformity).
• PIP Joint Capsule & Checkrein Ligaments: Dense contracture of the retrocondylar checkrein ligaments and accessory collateral ligaments anchors the PIP joint in severe fixed flexion.
• Extensor Hood & Central Slip: Chronic PIP flexion forces the lateral bands to subluxate volarly, stretching and attenuating the central slip, resulting in a fixed, non-reducible boutonniere deformity.

3. Pathogenesis

The pathogenesis of systemic sclerosis is an orchestrated biological cascade comprising three interdependent processes: microvascular endothelial injury, adaptive and innate immune dysregulation, and relentless, autonomous tissue fibrosis.

Endothelial Injury & Obliterative Vasculopathy

The initial pathological insult involves widespread microvascular endothelial cell damage triggered by circulating anti-endothelial cell antibodies, ischemia-reperfusion stress, and environmental triggers in genetically susceptible hosts. Activated endothelial cells undergo apoptosis, upregulate cellular adhesion molecules (ICAM-1, VCAM-1), and alter local vasoactive mediator production. There is a profound imbalance characterized by marked downregulation of vasodilators (prostacyclin, endothelial nitric oxide synthase) and severe hypersecretion of endothelin-1 (ET-1), a potent vasoconstrictor and smooth muscle mitogen.

Endothelial-to-mesenchymal transition (EndoMT) ensues, wherein endothelial cells lose their apical-basal polarity and transdifferentiate into alpha-smooth muscle actin (alpha-SMA)-positive myofibroblasts. This transformation, combined with platelet aggregation and perivascular adventitial fibrosis, drives concentric intimal proliferation. The progressive luminal obliteration reduces resting digital blood flow, creating chronic tissue hypoxia and precipitating painful digital ulceration and ischemic gangrene.

Immune Dysregulation & Autoantibody Profiles

Early perivascular inflammatory infiltrates consist predominantly of activated CD4+ T helper cells displaying a Th2 and Th17 phenotype, alongside activated macrophages and B lymphocytes. Th2 cytokines, including interleukin-4 (IL-4) and interleukin-13 (IL-13), stimulate extracellular matrix synthesis and alternative macrophage activation (M2 phenotype). B cells produce disease-defining autoantibodies that correlate with phenotypic subsets: anti-centromere antibodies (ACA) in limited cutaneous disease, and anti-topoisomerase I (anti-Scl-70) or anti-RNA polymerase III antibodies in diffuse cutaneous disease. Anti-RNA polymerase III antibodies have been directly linked to intense paraneoplastic immune activation and a high risk of scleroderma renal crisis.

Fibroblast Hyperactivation & Extracellular Matrix Deposition

The final common pathway is autonomous hyperactivation of tissue fibroblasts. Under continuous stimulation by transforming growth factor-beta (TGF-beta), platelet-derived growth factor (PDGF), and connective tissue growth factor (CTGF / CCN2), quiescent dermal and synovial fibroblasts differentiate into contractile myofibroblasts. These cells produce excessive quantities of Type I, Type III, and Type VI collagen, fibronectin, and proteoglycans. Concurrently, matrix metalloproteinases (MMPs) are downregulated while tissue inhibitors of metalloproteinases (TIMPs) are upregulated, preventing matrix degradation. In the hand, this dense, cross-linked extracellular matrix stiffens the dermis, subcutaneous tissues, tenosynovial sheaths, and periarticular capsuloligamentous structures, culminating in progressive hidebound joint contractures.

Mechanisms of Dystrophic Calcinosis Cutis

Calcinosis cutis in systemic sclerosis is dystrophic, developing in the setting of normal serum calcium and phosphate concentrations. Persistent local tissue hypoxia, recurrent microvascular ischemia, and repetitive mechanical shear stress trigger cell membrane disruption and mitochondrial calcium overload. Devitalized cells release membrane-bound matrix vesicles enriched in alkaline phosphatase and annexin V, which act as nucleation centers for calcium hydroxyapatite crystal deposition. These crystalline conglomerates evoke a secondary foreign-body granulomatous reaction, creating painful, firm subcutaneous nodules that frequently erode through thinned dermis, leading to chronic draining sinus tracts and secondary bacterial infection.

4. Natural History

Systemic sclerosis is a rare disorder with an estimated prevalence of 150 to 300 cases per million and an annual incidence of 10 to 20 cases per million in North America and Western Europe. It exhibits a marked female predilection, with a female-to-male ratio ranging from 4:1 during childbearing years to 8:1 in mid-life. Peak age of onset is between 30 and 50 years.

Clinical Trajectory by Disease Subtype

The natural history diverges sharply between the two major clinical subsets:

• Limited Cutaneous Systemic Sclerosis (lcSSc, ~70% of cases): Characterized by an insidious onset. Raynaud’s phenomenon frequently precedes clinically apparent skin changes by 5 to 10 years. Cutaneous involvement remains restricted to the distal extremities (distal to the elbows and knees) and the face. Although cutaneous progression is indolent, patients develop severe cumulative microvascular complications over decades, including recurrent digital ulcers, extensive dystrophic calcinosis cutis, telangiectasias, and isolated precapillary pulmonary arterial hypertension (PAH), which occurs in 10% to 15% of patients late in their disease course.
• Diffuse Cutaneous Systemic Sclerosis (dcSSc, ~30% of cases): Exhibits an aggressive, rapid clinical course. Raynaud’s phenomenon begins concurrently with or shortly preceding diffuse skin induration. The initial phase is characterized by painful, pruritic “puffy” non-pitting edema of the hands and limbs, rapidly progressing within 12 to 36 months to dense hidebound fibrosis involving the arms, thighs, chest, and abdomen. Patients face an early window of high vulnerability (first 3 to 5 years) for life-threatening internal organ complications, notably interstitial lung disease (ILD), scleroderma renal crisis (SRC), and myocardial fibrosis. After 3 to 5 years, cutaneous thickening often plateaus or partially regresses, but established musculoskeletal joint contractures and hand deformities remain irreversible.

Prognosis & Functional Deterioration

Overall 10-year survival is approximately 70% to 80%, with mortality significantly worse in dcSSc (10-year survival 65% to 75%) compared to lcSSc (10-year survival 80% to 90%). Pulmonary complications (ILD and PAH) represent the leading causes of death. In the musculoskeletal system, untreated hand involvement follows a predictable trajectory of functional deterioration: persistent ischemic digital pain leads to disuse; recurring digital tip ulcerations trigger terminal tuft resorption (acro-osteolysis); and periarticular capsular fibrosis locks the PIP joints in flexion and the thumb in adduction, producing a functional claw hand with profound loss of pinch and cylindrical grasp.

5. Clinical Presentation

History

A structured clinical history must elicit specific vascular, musculoskeletal, and systemic symptoms to narrow the diagnostic differential and define functional impairment:

• Vascular Characteristics: Cold-induced or emotional stress-induced triphasic color changes of the digits (initial pallor from arterial vasospasm, followed by cyanosis from deoxygenation, and reactive rubor upon reperfusion). Presence of severe, constant, throbbing digital tip pain, rest pain, or nocturnal pain indicating critical tissue ischemia.
• Hand Stiffness & Deformity: History of early “puffy finger” edema progressing to skin tightness, loss of skin turgor, and inability to make a full fist. Progression of PIP joint flexion contractures, loss of first web space span, and inability to hold eating utensils, write, or perform personal hygiene.
• Ulceration & Calcinosis History: History of recurrent, non-healing digital ulcers over the fingertips or extensor surfaces of the PIP and MCP joints. Spontaneous extrusion of chalky, painful white material from subcutaneous nodules.
• Review of Systems: Gastrointestinal symptoms (dysphagia for solids, severe retrosternal pyrosis, early satiety, bloating, diarrhea/constipation), cardiopulmonary symptoms (exertional dyspnea, dry cough, reduced exercise tolerance), and new-onset accelerated hypertension or visual changes (warning signs for scleroderma renal crisis).

Physical Exam

Physical examination demands rigorous inspection, systematic palpation of skin and tendons, joint range of motion documentation, and specialized vascular provocative maneuvers:

• Modified Rodnan Skin Score (mRSS): [Systematic clinical palpation of skin thickness graded 0 (normal), 1 (mild thickness), 2 (moderate thickness), 3 (severe hidebound thickness unable to be pinched) across 17 anatomical body areas: face, anterior chest, abdomen, bilateral fingers, hands, forearms, upper arms, thighs, lower legs, and feet; total score 0 to 51] -> Total score ≥14 or a rapid increase of ≥5 points over 6 months indicates aggressive diffuse cutaneous disease and heightened visceral risk [Sensitivity 88%, Specificity 90%].
• Modified Allen Test: [Simultaneous manual compression of the radial and ulnar arteries at the wrist while the patient clenches their fist three times, followed by maintaining passive digital extension while releasing one artery to observe palmar and digital flush] -> Delayed capillary reperfusion exceeding 5 to 7 seconds indicates palmar arch or target artery occlusive vasculopathy [Sensitivity 80%, Specificity 85%].
• Tendon Friction Rub Assessment: [Palpation of extensor and flexor tendon sheaths at the wrist, fingers, knees, and ankles during active and passive joint excursion] -> Palpable or audible leathery crepitus indicating dense fibrinous tenosynovial exudate and perivascular fibrosis [Sensitivity 45%, Specificity 98% for diffuse cutaneous systemic sclerosis].
• Nailfold Videocapillaroscopy (NVC): [Microscopic examination of the periungual nailfold capillary beds of digits 2 through 5 under 200x magnification] -> Detection of giant megacapillaries (>50 µm), avascular zones, microhemorrhages, and bushy ramified capillaries defining the scleroderma pattern [Sensitivity 91%, Specificity 92%].
• Hand Deformity & Motion Arc Measurement: Measure total active motion (TAM) of each digit, fixed flexion contracture of PIP joints (typically 30° to 70°), MCP joint hyperextension or fixed subluxation, and the first web space angle between the thumb and index metacarpals (normal 45° to 50°; pathological contracture <30°).
• Inspection of Calcinosis & Ulcers: Differentiate ischemic digital tip ulcers (punched-out, deep, exquisitely painful, situated at the pulp) from mechanical extensor ulcers (situated over the dorsal aspect of contracted PIP or MCP joints due to chronic skin stretch and breakdown). Palpate subcutaneous calcinosis along the volar pulps, PIP joints, and olecranon.

6. Imaging and Diagnostic Studies

Plain Radiography

Standard plain radiographs of the hands and wrists (bilateral posteroanterior, lateral, and oblique views) represent the gold standard initial imaging evaluation. Radiographic hallmarks include:

• Acro-osteolysis: Resorption of the terminal ungual tufts of the distal phalanges. Quantified by measuring the reduction in distal phalanx length and width relative to adjacent unaffected digits or historical baselines; advanced stages demonstrate complete pencil-in-cup resorption or total dissolution of the distal phalanx.
• Soft-Tissue Calcinosis Cutis: Flocculent, amorphous, dense radiopaque deposits localized within the subcutaneous tissues of the fingertips, periarticular capsules, and tendon sheaths.
• Articular Architecture & Alignment: Juxta-articular osteopenia, severe PIP joint flexion contractures, hyperextension or dorsal subluxation of the MCP joints, and preservation of joint space in early disease distinguishing SSc from rheumatoid arthritis. Advanced stages display secondary degenerative joint space loss, subchondral sclerosis, and ankylosis.

Vascular & Hemodynamic Studies

Objective vascular assessment is essential to map the macrovascular and microvascular tree prior to any surgical planning:

• Digital Color Duplex Ultrasound with Spectral Doppler: Directly interrogates the radial, ulnar, superficial palmar arch, and proper digital arteries. Assesses vessel wall intimal thickening, calculates digital peak systolic velocity (PSV), and identifies segmental thrombi or monophasic, high-resistance, dampened waveforms characteristic of fixed distal vasculopathy.
• Digital Brachial Index (DBI) & Photoplethysmography: Evaluates digital systolic pressure utilizing a miniature pneumatic cuff and infrared photoplethysmography sensor placed on the digital pulp. A normal DBI is >0.70; a DBI <0.50 denotes critical digital ischemia, and a flatline pulse volume recording confirms severe microvascular occlusion.
• CT Angiography (CTA) or MR Angiography (MRA): Indicated when proximal macrovascular disease or surgical sympathectomy is being evaluated. Maps the upper extremity arterial tree from the subclavian down to the palmar arches, ruling out proximal embolic sources, subclavian stenosis, and documenting ulnar artery occlusion in Guyon’s canal.

Serology & Laboratory Workup

Serum autoantibodies define the diagnostic subset and guide multidisciplinary organ surveillance:

• Antinuclear Antibodies (ANA): Positive in >95% of patients (typically exhibiting a centromere, nucleolar, or speckled immunofluorescence pattern).
• Anti-Centromere Antibodies (ACA): Present in 60% to 80% of patients with lcSSc. Strongly associated with CREST features, low risk of renal crisis, but elevated risk of late pulmonary arterial hypertension (PAH).
• Anti-Topoisomerase I Antibodies (Anti-Scl-70): Present in 30% to 40% of patients with dcSSc. Strongly associated with severe progressive cutaneous fibrosis, peripheral digital vasculopathy, and fibrosing interstitial lung disease (ILD).
• Anti-RNA Polymerase III Antibodies: Present in 10% to 20% of patients with dcSSc. Highly predictive of rapid, extensive skin induration, high risk of Scleroderma Renal Crisis (SRC), and co-incident malignant neoplasms.
• Inflammatory Markers & Renal Surveillance: Erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) are typically normal or only mildly elevated; marked elevation suggests overlap myositis, arthritis, or secondary osteomyelitis. Routine screening includes serum creatinine, estimated GFR, and quantitative urinalysis for proteinuria.

7. Classification

Classification of systemic sclerosis utilizes the internationally validated 2013 ACR/EULAR Classification Criteria to confirm disease diagnosis, followed by clinical phenotyping into limited or diffuse subsets to direct surgical decision-making and organ surveillance.

2013 ACR/EULAR Classification Criteria for Systemic Sclerosis

A patient is classified as having definitive systemic sclerosis if they accumulate a total score of 9 points or greater across the 8 clinical and laboratory domains:

Subtype Differentiation: Limited Cutaneous vs. Diffuse Cutaneous SSc

Stratification into limited or diffuse subsets defines clinical trajectory, organ complication risk, and hand surgical management:

8. Treatment

Medical / Nonoperative

Nonoperative management represents the primary foundation of care and must be optimized before considering surgical reconstruction:

• First-Line Vasodilator Therapy: Dihydropyridine calcium channel blockers (extended-release nifedipine 30 to 60 mg daily, or amlodipine 5 to 10 mg daily). Titrate to maximum tolerated dose avoiding symptomatic hypotension.
• Second-Line / Adjunctive Vasodilator Therapy: Phosphodiesterase-5 (PDE-5) inhibitors (sildenafil 20 to 50 mg three times daily, or tadalafil 20 mg once daily). Synergistically augments cyclic GMP-mediated vasodilation.
• Third-Line / Refractory Vasodilator Therapy: Endothelin receptor antagonists (bosentan 62.5 to 125 mg twice daily; proven to reduce the recurrence of new digital ulcers by 30% to 50%). For acute critical digital ischemia, intravenous prostacyclin analogues (iloprost continuous infusion 0.5 to 2.0 ng/kg/min for 5 to 7 consecutive days) provide potent microvascular recruitment.
• Antiplatelet Coverage: Low-dose aspirin (81 mg daily) to prevent microthrombosis in stenotic digital vessels.
• Immunomodulatory Therapy for Fibrosis: Directed by rheumatology for active cutaneous and visceral disease. Mycophenolate mofetil (MMF, 2 to 3 g daily) is first-line for cutaneous induration and active ILD; cyclophosphamide, rituximab, or tocilizumab for refractory progression; autologous hematopoietic stem cell transplantation (AHSCT) for severe, rapidly progressive early dcSSc.
• Non-Pharmacological Physical & Hand Therapy: Structured, supervised hand therapy incorporating daily active and passive range-of-motion stretching, joint mobilizations, thermal biofeedback, paraffin baths, and night splinting. Dynamic extension splinting counters PIP flexion, while static C-splints preserve the first web space.
• Objective Failure Criteria: Persistent or enlarging ischemic digital ulcers failing to heal after 4 to 6 weeks of maximal dual vasodilator therapy; rest pain refractory to analgesics; progressive digital tip demarcation or dry gangrene; or fixed contractures causing skin breakdown.

Operative

The overarching goals of surgical intervention in the scleroderma hand are to alleviate ischemic rest pain, restore microvascular perfusion to heal refractory digital ulcers, stabilize destroyed or contracted joints in functional alignment, decompress entrapped peripheral nerves, and debride painful, ulcerating calcinosis cutis:

• Periarterial Adventitial Digital Sympathectomy (Flatt / Morgan Technique): Performed under high loupe magnification (3.5x to 4.5x) or operating microscope through palmar incisions proximal to the web spaces or midlateral digital approaches. The common and proper digital arteries are mobilized, and the hyperplastic adventitial sympathetic nerve plexus is stripped circumferentially over a 1.5 to 2.0 cm segment using micro-scissors and micro-forceps. Eliminates excessive sympathetic alpha-adrenergic vasoconstrictor tone and interrupts afferent nociceptive fibers. Achieves immediate relief of ischemic rest pain in >90% of patients and promotes complete ulcer healing in 80% to 92% within 6 to 12 weeks.
• Chemical Sympathectomy via Botulinum Toxin A (Botox): Minimally invasive office-based or intraoperative intervention. A total dose of 50 to 100 units of onabotulinumtoxinA (diluted in preservative-free normal saline, 10 to 20 units per site) is injected along the neurovascular bundles in the distal palm, web spaces, and along the digital flexor sheaths adjacent to the common and proper digital vessels. Blocks vesicular release of acetylcholine from sympathetic postganglionic cholinergic terminals and inhibits recruitment of alpha-2C adrenergic receptors, downregulating substance P and CGRP. Yields rapid pain relief within 48 to 72 hours, increases digital surface temperature, and promotes ulcer healing in 75% to 85% of cases with an effect lasting 4 to 6 months.
• Calcinosis Cutis Debulking & Curettage: Reserved for symptomatic deposits causing intractable localized pain, mechanical joint impingement, skin ulceration, or nerve compression. Small linear or curvilinear incisions are placed directly over the lesion, respecting skin lines. The fibrous pseudocapsule is incised, and the pasty or granular calcium hydroxyapatite is meticulously evacuated using micro-curettes and copious saline irrigation. Avoid wide or aggressive skin excision; the overlying hidebound skin is exquisitely thinned and ischemic. Preserve adjacent digital nerves, which are often encased in calcific debris. Close skin loosely with interrupted monofilament or allow open secondary healing with non-adherent dressings.
• Proximal and Distal Interphalangeal Joint Arthrodesis: Indicated for fixed PIP flexion contractures >60° with dorsal skin breakdown, chronic subluxation, or joint destruction. Exposed through a dorsal curvilinear or midlateral incision, preserving the attenuated extensor apparatus. Articular cartilage is resected to flat cancellous surfaces. Rigid fixation is achieved using headless cannulated compression screws (2.5 mm or 3.0 mm) or crossed Kirschner wires. PIP joints are fused in progressive flexion: index finger at 30° to 35°, middle finger at 35° to 40°, ring finger at 40° to 45°, and small finger at 45° to 50°; DIP joints are fused in 0° to 10° flexion. Silicone or surface-replacement PIP arthroplasty is strictly contraindicated in systemic sclerosis due to severe periarticular capsulofibrosis, high incidence of dorsal skin necrosis, and catastrophic implant extrusion rates.
• First Web Space Contracture Release: Severe thumb adduction contracture eliminates grasp span. Corrected via a single or multiple Z-plasty or four-flap Z-plasty of the dorsal skin, followed by surgical release of the contracted fascia of the first dorsal interosseous muscle and fractional recession of the transverse head of the adductor pollicis origin from the third metacarpal. If soft-tissue deficit persists, coverage is augmented with a full-thickness skin graft or dermal matrix substitute. A temporary K-wire across the first and second metacarpals maintains 40° of palmar abduction for 4 weeks.
• Digital Amputation / Terminalization: Reserved strictly for non-salvageable dry mummification, wet gangrene, or deep osteomyelitis unresponsive to revascularization and intravenous antibiotics. Performed ultra-conservatively, resecting only clearly necrotic tissue and preserving maximal bone length. Primary closure without tension or healing by secondary intention is preferred over aggressive proximal revision.

Indications & Contraindications

Explicit numerical thresholds and clinical parameters dictate operative selection:

• Indications for Digital Sympathectomy: Digital ulcer non-healing >4 to 6 weeks despite maximal dual vasodilator medical therapy; rest pain refractory to analgesia; or threatened digital viability.
• Indications for PIP Arthrodesis: Fixed PIP flexion contracture >60° producing functional impairment, hygiene failure, or dorsal skin ulceration.
• Indications for Web Space Release: First web space contracture angle <30° between first and second metacarpals severely compromising cylindrical grasp.
• Indications for Calcinosis Debulking: Subcutaneous calcinosis deposits >5 mm causing persistent pain, skin breakdown, chronic sinus drainage, or digital nerve compression.
• Indications for Nerve Decompression: Documented electrodiagnostic compressive median or ulnar neuropathy failing conservative splinting.
• Absolute Contraindications: Acute ascending cellulitis or deep space infection without prior drainage; unstable scleroderma renal crisis with severe accelerated hypertension; uncontrolled severe pulmonary arterial hypertension (WHO functional class IV) creating prohibitive perioperative anesthetic mortality risk; complete lack of proximal vascular inflow without reconstructable targets.
• Relative Contraindications: Active cigarette smoking (strongly discourages elective revascularization); severe hidebound skin overlying proposed arthrodesis incisions (requires staged revascularization or nonoperative splinting first); PIP joint silicone arthroplasty (contraindicated due to universal failure).

9. Outcome

Evidence-based outcomes in systemic sclerosis hand surgery demonstrate high clinical efficacy when procedures are tailored to vascular optimization and stable skeletal alignment:

• DASH & QuickDASH Functional Improvement: Preoperative scores in patients with active digital ulcers and severe contractures typically average 55 to 70 points (reflecting severe disability). Following successful periarterial sympathectomy and contracture stabilization, patients demonstrate a statistically and clinically meaningful mean reduction of 15 to 25 points, reflecting restored capacity for feeding, dressing, and hygiene.
• Cochin Hand Function Scale (CHFS) Responsiveness: Highly sensitive 18-item validated tool for inflammatory and scleroderma hand involvement (scale 0 to 90). Structured hand therapy paired with targeted surgical intervention yields significant reductions in functional scores from a baseline mean of 42 to 24 at 12 months.
• Periarterial Digital Sympathectomy Efficacy: Provides immediate abolition of resting ischemic pain in 85% to 92% of cases. Complete digital ulcer healing occurs in 80% to 92% of treated digits within a mean timeframe of 6 to 10 weeks. Ulcer recurrence occurs in approximately 15% to 25% at 2 to 3 years, which can be managed with repeat chemical sympathectomy.
• Botulinum Toxin A Perfusion & Ulcer Resolution: Produces documented increases in laser Doppler digital perfusion flux (mean increase of 40% to 60%) and digital pulp surface temperature (mean increase of 1.5°C to 2.5°C). Complete ulcer healing is achieved in 75% to 85% of digits within 8 weeks, with pain score (VAS 0 to 10) reductions from 8.2 to 2.4 lasting 4 to 6 months.
• Skeletal Arthrodesis Union Rates: Rigid compression screw or crossed K-wire arthrodesis of PIP and DIP joints achieves solid osseous union in 80% to 88% of scleroderma digits. Delayed union occurs in 12% to 15%, and fibrous nonunion occurs in 8% to 12%. Fibrous nonunion in this cohort is frequently stable and pain-free, fulfilling the clinical goal of eliminating contracture and stabilizing pinch.
• First Web Space Span Restoration: Surgical Z-plasty combined with adductor pollicis recession restores an average of 18° to 25° of first web space intermetacarpal angle, significantly expanding functional hand grasp and improving key pinch strength.

10. Complications

Surgical interventions in systemic sclerosis carry substantial complication risks due to microvascular occlusive disease, compromised cutaneous perfusion, thin hidebound dermis, and systemic immunosuppression. Complications are structured across three distinct surgical phases:

11. Pearls and Pitfalls

Technical Pearls

• Environmental Thermal Regulation: Maintain the operating room ambient temperature at 22°C to 24°C, warm all intravenous fluids, and apply active forced-air warming blankets. Intraoperative hypothermia triggers profound peripheral alpha-adrenergic vasospasm that can cause irreversible intraoperative digital thrombosis.
• Tourniquet Discipline: Minimize or avoid tourniquet use whenever feasible. If a forearm tourniquet is necessary, limit inflation pressure to <200 mmHg and restrict inflation time to under 45 to 60 minutes. Release the tourniquet and achieve complete thermal and pharmacological vasodilation (topical papaverine) before assessing digital viability and closing skin.
• Microsurgical Adventitial Stripping Depth: During digital sympathectomy, under 3.5x to 4.5x magnification, place the micro-scissors strictly in the adventitial-medial cleavage plane. Strip 1.5 to 2.0 cm of adventitia circumferentially. Ensure the adventitia is completely peeled off rather than partially thinned, as residual bands harbor intact sympathetic fibers that maintain vasospasm.
• Zero-Tension Skin Closure: Sclerotic, hidebound dermis has negligible elastic recoil. Never force skin edges together under tension. Use widely spaced, interrupted 5-0 or 6-0 monofilament sutures, or allow open intervals to heal uneventfully by secondary intention using non-adherent petrolatum or collagen gauze.
• Pre-incision Botulinum Toxin Infiltration: In patients undergoing joint fusion or calcinosis excision with severe baseline digital vasospasm, inject 10 to 20 units of botulinum toxin A adjacent to the proper digital neurovascular bundles prior to skin incision or at the conclusion of surgery to safeguard postoperative microvascular inflow.

Surgical Pitfalls

• The PIP Arthroplasty Trap: Never attempt silicone or surface-replacement PIP arthroplasty in systemic sclerosis. The dense, progressive periarticular fibrosis and compromised dermal envelope guarantee rapid implant extrusion, recurrent stiffening, or deep infection. Arthrodesis in functional position is the only validated standard.
• The Aggressive Ulcer Debridement Trap: Do not excise the margins of an ischemic digital ulcer in an un-revascularized digit. Unlike venous or diabetic ulcers, scleroderma ulcers stem from microvascular arterial insufficiency; excising the edge enlarges the wound into marginally perfused tissue, precipitating acute necrosis and digital amputation.
• Overlooking Ulnar Artery Occlusion: Do not assume digital ischemia is purely a microcapillary phenomenon. Always perform a modified Allen test and duplex Doppler to evaluate the ulnar artery; up to 50% of patients have ulnar artery thrombosis in Guyon’s canal that may alter revascularization strategy.
• The High-Dose Corticosteroid Trap: Avoid administering high-dose systemic corticosteroids (>15 mg/day prednisone equivalent) perioperatively. Moderate-to-high dose corticosteroid therapy in systemic sclerosis is a potent trigger for Scleroderma Renal Crisis (SRC), characterized by malignant hypertension and acute oliguric renal failure.

12. Controversy

Botulinum Toxin A vs. Open Surgical Periarterial Sympathectomy

A central debate in the management of refractory digital ischemia is whether chemical sympathectomy with botulinum toxin A should replace open surgical adventitial sympathectomy as the primary standard of care. Proponents of botulinum toxin A emphasize its minimally invasive nature, low complication profile, ease of office administration, and high ulcer healing rates (75% to 85%). Conversely, advocates of open surgical sympathectomy emphasize that microsurgical adventitial resection provides definitive, long-lasting anatomical denervation (persisting several years), whereas botulinum toxin A requires repeat injections every 4 to 6 months. Currently, most centers utilize botulinum toxin A as an initial frontline intervention, reserving open adventitial sympathectomy for recalcitrant cases or when concurrent open debridement of calcinosis or joint stabilization is planned.

Autologous Adipose-Derived Stem Cell Grafting (Lipofilling)

Autologous fat grafting (lipotransfer) into the sclerotic fingers and palm has emerged as an investigational regenerative therapy. Adipose tissue contains high concentrations of adipose-derived stem cells (ADSCs) within the stromal vascular fraction (SVF) that secrete potent pro-angiogenic and antifibrotic cytokines, including vascular endothelial growth factor (VEGF) and hepatocyte growth factor (HGF). Early prospective clinical series demonstrate improvements in skin elasticity, digital capillary density, and reduction in pain scores. However, critics highlight the lack of large, multicenter, randomized sham-controlled trials, variable graft volume survival in ischemic tissues, and the undefined longevity of clinical benefits.

Management of MCP Joint Deformities: Arthroplasty vs. Nonoperative Splinting

While PIP joint arthrodesis is universally accepted, surgical management of severe metacarpophalangeal (MCP) joint extension contractures and subluxation remains controversial. Some hand surgeons advocate for soft-tissue collateral ligament release combined with silicone spacer arthroplasty in highly selected patients who retain active flexor tendon excursion, aiming to preserve functional finger flexion. However, other surgical authorities caution that the severe hidebound dermal envelope and intrinsic muscle fibrosis lead to an unacceptable rate of skin dehiscence and recurrent stiffness, recommending that operative intervention at the MCP level be avoided in favor of aggressive dynamic splinting and physical therapy.

Perioperative Anticoagulation Protocols

The role and intensity of perioperative anticoagulation during digital sympathectomy and revascularization remain unstandardized. Given the high prevalence of microthrombosis in stenotic digital vessels, some centers routinely administer therapeutic low-molecular-weight heparin or continuous intravenous iloprost infusions perioperatively. Opponents argue that systemic anticoagulation substantially increases the incidence of wound hematoma, which, in the setting of thinned, ischemic skin, inevitably precipitates skin flap necrosis and deep infection. Current practice generally favors maintaining antiplatelet monotherapy (aspirin 81 mg daily) while reserving systemic anticoagulation for patients with confirmed acute propagating macrovascular thrombosis.

13. Evidence-Based Synthesis

Modern clinical decision-making is grounded in high-quality randomized controlled trials and prospective registry analyses, corroborated by seminal biomechanical and anatomical descriptions.

14. References

• van den Hoogen F, Khanna D, Fransen J et al. 2013 classification criteria for systemic sclerosis: an American college of rheumatology/European league against rheumatism collaborative initiative. Ann Rheum Dis. 2013. doi:10.1136/annrheumdis-2013-204424 [Level IV: Clinical Case Series / Cohort Study]
• Beldner S, Rabinovich RV, Polatsch DB. Scleroderma of the Hand: Evaluation and Treatment. J Am Acad Orthop Surg. 2020. doi:10.5435/JAAOS-D-19-00547 [Level IV: Clinical Case Series / Cohort Study]
• Williams AA, Carl HM, Lifchez SD. The Scleroderma Hand: Manifestations of Disease and Approach to Management. J Hand Surg Am. 2018. doi:10.1016/j.jhsa.2018.03.021 [Level IV: Clinical Case Series / Cohort Study]
• Traineau H, Aggarwal R, Monfort JB et al. Treatment of calcinosis cutis in systemic sclerosis and dermatomyositis: A review of the literature. J Am Acad Dermatol. 2020. doi:10.1016/j.jaad.2019.07.006 [Level I: Systematic Review / Meta-Analysis]
• Parodis I, Girard-Guyonvarc’h C, Arnaud L et al. EULAR recommendations for the non-pharmacological management of systemic lupus erythematosus and systemic sclerosis. Ann Rheum Dis. 2024. doi:10.1136/ard-2023-224416 [Level I: Systematic Review / Meta-Analysis]

15. Master Class Pro-Tip

When approaching ischemic digital ulcers and severe flexion contractures in systemic sclerosis, success hinges on prioritizing vascular revascularization before correcting musculoskeletal deformities. Never attempt bony fusion, tendon release, or calcinosis debridement in a cold, ischemic digit without first restoring digital perfusion. Periarterial digital sympathectomy or localized botulinum toxin A infiltration must be performed first to relieve intense microvascular vasospasm and optimize capillary inflow. Intraoperatively, maintain strict environmental warmth (ambient room temperature >22°C), avoid prolonged tourniquet inflation, utilize 3.5x to 4.5x magnification to preserve fragile digital neurovascular bundles encased in hidebound fibrosis, and under no circumstances close sclerotic skin under tension. If skin edges do not gently appose, allow the wound to heal by secondary intention or apply a loose collagen dressing; forceful closure in scleroderma almost invariably precipitates flap necrosis, deep infection, and catastrophic digital loss.

Master Class Surgical Pearl: Hand Surgery & Vascular Optimization in Systemic Sclerosis